KMID : 0043320210440070725
|
|
Archives of Pharmacal Research 2021 Volume.44 No. 7 p.725 ~ p.740
|
|
Is loss of smell an early predictor of COVID-19 severity: a systematic review and meta-analysis
|
|
Purja Sujata
Shin Ho-Cheol Lee Ji-Yun Kim Eun-Young
|
|
Abstract
|
|
|
Anecdotal evidence suggests that the severity of coronavirus disease of 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is likely to be distinguished by variations in loss of smell (LOS). Thus, we conducted a meta-analysis of 45 articles that include a total of 42,120 COVID-19 patients from 17 different countries to demonstrate that severely ill or hospitalized COVID-19 patients have a lesser chance of experiencing LOS than non-severely ill or non-hospitalized COVID-19 patients (odds ratio?=?0.527 [95% CI 0.373?0.744; p?0.001] and 0.283 [95% CI 0.173?0.462; p?0.001], respectively). We also proposed a possible mechanism underlying the association of COVID-19 severity with anosmia, which may explain why patients without sense of smell develop severe COVID-19. Variations in LOS according to the severity of COVID-19 is a global phenomenon, with few exceptions. Since severely ill patients have a lower rate of anosmia, patients without anosmia should be monitored more closely in the early stages of COVID-19, for early diagnosis of severity of illness. An understanding of how the severity of COVID-19 infection and LOS are associated has profound implications for the clinical management and mitigation strategies for the disease.
|
|
KEYWORD
|
|
COVID-19, SARS-CoV-2, Anosmia, COVID-19 severity, COVID-19 hospitalization
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|